Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
100550992 | 10055099 | 2 | F | 20150513 | 20140402 | 20150630 | PER | US-SA-2014SA009858 | AVENTIS | 0.00 | A | F | Y | 0.00000 | 20150630 | N | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
100550992 | 10055099 | 1 | PS | AUBAGIO | TERIFLUNOMIDE | 1 | Unknown | D | UNKNOWN | 202992 | 7 | MG | COATED TABLET | QD | |||||
100550992 | 10055099 | 2 | C | WELLBUTRIN | BUPROPION HYDROCHLORIDE | 1 | D | 0 | QD | ||||||||||
100550992 | 10055099 | 3 | C | TRAZODONE | TRAZODONE HYDROCHLORIDE | 1 | D | 0 | QD |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
100550992 | 10055099 | 1 | Multiple sclerosis |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
100550992 | 10055099 | Lymphopenia | |
100550992 | 10055099 | Pruritus generalised |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
100550992 | 10055099 | 1 | 201302 | 0 |